Pasar al contenido principal

APLICACION DE NUEVOS ALGORITMOS BIOINFORMATICOS PARA EL ESTUDIO MASIVO DE MODIFICACIONES POST-TRADUCCIONALES EN ENFERMEDADES ASOCIADAS A REMODELADO VASCULAR

PID2024-155650NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pleiotropic impact of the loss of complex II in the organization of the respiratory chain and the mitochondrial ultrastructure

  • Esteban-Amo, María J.
  • Acín-Pérez, Rebeca
  • Fernandez-Martinez, Silvia
  • Calvo, Enrique
  • Vázquez, Jesús
  • Enríquez, José Antonio
  • Fuente, Miguel A. de la
  • Simarro-Grande, María
Succinate dehydrogenase (SDH, mitochondrial complex II) connects the tricarboxylic acid cycle and oxidative phosphorylation, and its dysfunction is associated with a broad spectrum of human diseases. It comprises a catalytic SDHA subunit and the electron-transferring SDHB subunit, which transfers electrons to the membrane-embedded SDHC/SDHD module where ubiquinone reduction occurs. Recessive defects in SDHA cause early-onset mitochondrial and neurodegenerative disorders, whereas heterozygous mutations in SDHB predispose to tumor development. A distinctive feature of SDHB deficiency is the accumulation of a stable assembly intermediate (CII-low) containing flavinated SDHA, whose functional relevance remains largely unexplored. Despite extensive characterization of SDH-related metabolic alterations, its direct impact on mitochondrial respiration and respiratory chain architecture has remained insufficiently defined. To address this critical gap, we established human cellular models deficient in either SDHA or SDHB, enabling discrimination between complete loss of complex II and conditions marked by CII-low accumulation. We found that CII-low lacked uncoupled activity despite containing flavinated SDHA. In both models, the loss of complex II activity caused severe impairment of mitochondrial respiration and ATP production. These changes were accompanied by marked remodeling of the respiratory chain, with complex I being the most consistently affected complex, as shown by BN-PAGE and proteomic analyses. At the organelle level, SDH deficiency induced mitochondrial abnormalities, including reduced cristae density. The similarity between the two knockout models indicates that the presence of CII-low does not make a major contribution to the observed phenotypes. These findings indicate that SDH deficiency contributes to disease through disruption of mitochondrial respiratory chain organization and ultrastructure., MS and MAF acknowledge grant PID2023-150506OB-I00 funded by MICIU and VA172P20 funded by Junta de Castilla y León. JV acknowledges grants PID2021-122348NB-I00 and PID2024-155650NB-I00 funded by MICIU and by “ERDF A way of making Europe”, PLEC2022-009298, PLEC2022-009235 and EQC2021-007053-P funded by MICIU and by “European Union NextGenerationEU/ PRTR”, S2022/BMD-7333-CM (INMUNOVAR-CM) funded by Comunidad de Madrid and LCF/PR/HR22/52420019 funded by ‘la Caixa’ Foundation. MJEA was supported by a predoctoral contract from the University of Valladolid., Peer reviewed